{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:54Z","timestamp":1792783494822,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Akrimax Pharmaceuticals, LLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40268-015-0116-6","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T04:57:48Z","timestamp":1450673868000},"page":"53-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project"],"prefix":"10.1007","volume":"16","author":[{"given":"Marjorie","family":"McMillan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith S.","family":"Rotenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold B.","family":"Sterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Thevathasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munish","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Sandulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"116_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/1947-2714.93881","volume":"4","author":"RA Dar","year":"2012","unstructured":"Dar RA, Chowdri NA, Parray FQ, Wani SH. An unusual case of Hashimoto\u2019s thyroiditis with four lobed thyroid gland. N Am J Med Sci. 2012;4:151\u20133.","journal-title":"N Am J Med Sci."},{"key":"116_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12659\/AJCR.881371","volume":"12","author":"S Yaturu","year":"2011","unstructured":"Yaturu S, Fontinot J, Rowland T. Mixed medullary thyroid cancer and follicular cancer. Am J Case Rep. 2011;12:1\u20134.","journal-title":"Am J Case Rep."},{"key":"116_CR3","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1089\/thy.2013.0661","volume":"24","author":"HM Robertson","year":"2014","unstructured":"Robertson HM, Narayanaswamy AK, Pereira O, et al. Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database. Thyroid. 2014;24:1765\u201371.","journal-title":"Thyroid."},{"key":"116_CR4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/jc.2004-1306","volume":"90","author":"F Santini","year":"2005","unstructured":"Santini F, Pinchera A, Marsili A, et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid disease. J Clin Endocrinol Metab. 2005;90:124\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1001\/archinte.165.15.1714","volume":"165","author":"A Roos","year":"2005","unstructured":"Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout S. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med. 2005;165:1714\u201320.","journal-title":"Arch Intern Med"},{"key":"116_CR6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-119-6-199309150-00009","volume":"119","author":"SJ Mandel","year":"1993","unstructured":"Mandel SJ, Brent GA, Larscn PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993;119:492\u2013502.","journal-title":"Ann Intern Med"},{"key":"116_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11598070-000000000-00000","volume":"72","author":"D Khandelwal","year":"2012","unstructured":"Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: who to treat and how. Drugs. 2012;72:17\u201333.","journal-title":"Drugs."},{"key":"116_CR8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","volume":"23","author":"L Liwanpo","year":"2009","unstructured":"Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23:781\u201392.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"116_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4292\/wjgpt.v5.i3.105","volume":"5","author":"R Badillo","year":"2014","unstructured":"Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5:105\u201312.","journal-title":"World J Gastrointest Pharmacol Ther."},{"key":"116_CR10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1007\/s10620-014-3181-8","volume":"59","author":"E Cohen","year":"2014","unstructured":"Cohen E, Bolus R, Khanna D, et al. GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci. 2014;59:2488\u201396.","journal-title":"Dig Dis Sci"},{"key":"116_CR11","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMcp1113994","volume":"367","author":"A Fasano","year":"2012","unstructured":"Fasano A, Catassi C. Clinical practice: celiac disease. N Engl J Med. 2012;367:2419\u201326.","journal-title":"N Engl J Med"},{"key":"116_CR12","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2146\/ajhp060033","volume":"63","author":"AD Miller","year":"2006","unstructured":"Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm. 2006;63:1852\u20137.","journal-title":"Am J Health Syst Pharm"},{"key":"116_CR13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0004-27302010000500002","volume":"54","author":"LS Ward","year":"2010","unstructured":"Ward LS. The difficult patient: drug interaction and the influence of concomitant diseases on the treatment of hypothyroidism. Arq Bras Endocrinol Metabol. 2010;54:435\u201342.","journal-title":"Arq Bras Endocrinol Metabol."},{"key":"116_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.12659\/AJCR.883788","volume":"14","author":"JB Groener","year":"2013","unstructured":"Groener JB, Lehnhoff D, Piel D, et al. Subcutaneous application of levothyroxine as successful treatment option in a patient with malabsorption. Am J Case Rep. 2013;14:48\u201351.","journal-title":"Am J Case Rep."},{"key":"116_CR15","first-page":"244","volume":"86","author":"DY Gaitonde","year":"2012","unstructured":"Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. Am Fam Physician. 2012;86:244\u201351.","journal-title":"Am Fam Physician"},{"key":"116_CR16","doi-asserted-by":"crossref","first-page":"E1454","DOI":"10.1210\/jc.2014-1217","volume":"99","author":"M Cellini","year":"2014","unstructured":"Cellini M, Santaguida MG, Gatto I, et al. Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine. J Clin Endocrinol Metab. 2014;99:E1454\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR17","first-page":"451","volume":"18","author":"G Ianiro","year":"2014","unstructured":"Ianiro G, Mangiola F, Di Rienzo TA, et al. Levothyroxine absorption in health and disease, and new therapeutic perspectives. Eur Rev Med Pharmacol Sci. 2014;18:451\u20136.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"116_CR18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MED.0000000000000003","volume":"20","author":"S Benvenga","year":"2013","unstructured":"Benvenga S. When thyroid hormone replacement is ineffective? Curr Opin Endocrinol Diabetes Obes. 2013;20:467\u201377.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"116_CR19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/acta.0.1100483","volume":"110","author":"K Hasselstr\u00f6m","year":"1985","unstructured":"Hasselstr\u00f6m K, Siersbaek-Nielsen K, Lumholtz IB, Faber J, Kirkegaard C, Friis T. The bioavailability of thyroxine and 3,5,3\u2032-triiodothyronine in normal subjects and in hyper- and hypothyroid patients. Acta Endocrinol (Copenh). 1985;110:483\u20136.","journal-title":"Acta Endocrinol (Copenh)."},{"key":"116_CR20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/jc.2007-1544","volume":"93","author":"S Checchi","year":"2008","unstructured":"Checchi S, Montanaro A, Pasqui L, et al. l-Thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab. 2008;93:465\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR21","unstructured":"US Food and Drug Administration. International Conference on Harmonisation; good clinical practice: consolidated guideline; availability. Federal Register. 1997;62:25692\u2013709."},{"key":"116_CR22","unstructured":"US Department of Health and Human Services. Code of Federal Regulations. Title\u00a045 Public Welfare. Section\u00a046.116.7\u20138. US Department of Health and Human Services. 2009. http:\/\/www.hhs.gov\/ohrp\/policy\/ohrpregulations.pdf . Accessed 10 Dec 2015."},{"key":"116_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1467-789X.2009.00614.x","volume":"11","author":"R Padwal","year":"2010","unstructured":"Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11:41\u201350.","journal-title":"Obes Rev"},{"key":"116_CR24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1524-4733.2006.00091.x","volume":"9","author":"C McMillan","year":"2006","unstructured":"McMillan C, Bradley C, Razvi S, Weaver J. Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: the ThyTSQ. Value Health. 2006;9:132\u20139.","journal-title":"Value Health."},{"key":"116_CR25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7525-11-68","volume":"11","author":"EM Quinque","year":"2013","unstructured":"Quinque EM, Villringer A, Kratzsch J, Karger S. Patient-reported outcomes in adequately treated hypothyroidism\u2014insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ. Health Qual Life Outcomes. 2013;11:68.","journal-title":"Health Qual Life Outcomes."},{"key":"116_CR26","unstructured":"Virili C, Santaguida MG, Cellini M, Del Duca SC, Gargano L, Centanni M. Pilot study with softgel thyroxine preparation in the treatment of patients with T4 malabsorption due to gastric disorders. Endocr Rev. 2013;34:Abstract OR50-4."},{"key":"116_CR27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.amjmed.2011.09.003","volume":"125","author":"D Collins","year":"2012","unstructured":"Collins D, Wilcox R, Nathan M, Zubarik R. Celiac disease and hypothyroidism. Am J Med. 2012;125:278\u201382.","journal-title":"Am J Med"},{"key":"116_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12020-012-9814-9","volume":"43","author":"M Centanni","year":"2013","unstructured":"Centanni M. Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine. 2013;43:8\u20139.","journal-title":"Endocrine"},{"key":"116_CR29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-230X-11-25","volume":"11","author":"E Dorval","year":"2011","unstructured":"Dorval E, Rey JF, Soufflet C, Halling K, Barth\u00e9lemy P. Perspectives on gastroesophageal reflux disease in primary care: the REFLEX study of patient\u2013physician agreement. BMC Gastroenterol. 2011;11:25.","journal-title":"BMC Gastroenterol."},{"key":"116_CR30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1530\/EJE-12-1035","volume":"168","author":"JN Walker","year":"2013","unstructured":"Walker JN, Shillo P, Ibbotson V, et al. A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment. Eur J Endocrinol. 2013;168:913\u20137.","journal-title":"Eur J Endocrinol"},{"key":"116_CR31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1590\/S0103-507X2011000200019","volume":"23","author":"AL Vinagre","year":"2011","unstructured":"Vinagre AL, Souza MV. Levothyroxine absorption and difficult management of hypothyroid patients in the intensive care unit: two case reports and a literature review. Rev Bras Ter Intensiva. 2011;23:242\u20138.","journal-title":"Rev Bras Ter Intensiva."},{"key":"116_CR32","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","volume":"354","author":"M Centanni","year":"2006","unstructured":"Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354:1787\u201395.","journal-title":"N Engl J Med"},{"key":"116_CR33","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.3748\/wjg.v20.i30.10331","volume":"20","author":"E Lahner","year":"2014","unstructured":"Lahner E, Virili C, Santaguida MG, Annibale B, Centanni M. Helicobacter pylori infection and drugs malabsorption. World J Gastroenterol. 2014;20:10331\u20137.","journal-title":"World J Gastroenterol"},{"key":"116_CR34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","volume":"7","author":"WM Tunbridge","year":"1977","unstructured":"Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol (Oxf). 1977;7:481\u201393.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"116_CR35","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1210\/jc.2006-1557","volume":"91","author":"S Wilson","year":"2006","unstructured":"Wilson S, Parle JV, Roberts LM, et al. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J Clin Endocrinol Metab. 2006;91:4809\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"MP Vanderpump","year":"2011","unstructured":"Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39\u201351.","journal-title":"Br Med Bull"},{"key":"116_CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1503\/cmaj.110994","volume":"184","author":"A Ramadhan","year":"2012","unstructured":"Ramadhan A, Tamilia M. Treatment-refractory hypothyroidism. CMAJ. 2012;184:205\u20139.","journal-title":"CMAJ"},{"key":"116_CR38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1210\/jcem-71-3-764","volume":"71","author":"DS Ross","year":"1990","unstructured":"Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab. 1990;71:764\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR39","first-page":"107","volume":"43","author":"JV Parle","year":"1993","unstructured":"Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract. 1993;43:107\u20139.","journal-title":"Br J Gen Pract"},{"key":"116_CR40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Cararis","year":"2000","unstructured":"Cararis GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526\u201334.","journal-title":"Arch Intern Med"},{"key":"116_CR41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES\u00a0III). J Clin Endocrinol Metab. 2002;87:489\u201399.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR42","first-page":"485","volume":"36","author":"F Vaisman","year":"2013","unstructured":"Vaisman F, Coeli CM, Ward LS, et al. How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study. J Endocrinol Invest. 2013;36:485\u20138.","journal-title":"J Endocrinol Invest"},{"key":"116_CR43","doi-asserted-by":"crossref","unstructured":"Vig\u00e1rio Pdos S, Vaisman F, Coeli CM, et al. Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life\u2014a Brazilian multicentre study. Endocrine. 2013;44:434\u201340.","DOI":"10.1007\/s12020-013-9886-1"},{"key":"116_CR44","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/archinternmed.2010.436","volume":"170","author":"N Bolk","year":"2010","unstructured":"Bolk N, Visser TJ, Nijman J, et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170:1996\u20132003.","journal-title":"Arch Intern Med"},{"key":"116_CR45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11695-011-0452-8","volume":"22","author":"IG Rubio","year":"2012","unstructured":"Rubio IG, Galr\u00e3o AL, Santo MA, Zanini AC, Medeiros-Neto G. Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery. Obes Surg. 2012;22:253\u20138.","journal-title":"Obes Surg"},{"key":"116_CR46","unstructured":"Knapton K, Myers S. A study of non-response patterns. Quirks Marketing Research Media. 2005. http:\/\/www.quirks.com\/articles\/a2005\/20050106.aspx . Accessed 10 Dec 2015."},{"key":"116_CR47","volume-title":"Medicine use and shifting costs of healthcare","author":"IMS Institute for Healthcare Informatics","year":"2014","unstructured":"IMS Institute for Healthcare Informatics. Medicine use and shifting costs of healthcare. Danbury: IMS Health; 2014."},{"key":"116_CR48","first-page":"318","volume":"63","author":"M Ruchala","year":"2012","unstructured":"Ruchala M, Szczepanek-Parulska E, Zybek A. The influence of lactose intolerance and other gastro-intestinal tract disorders on l-thyroxine absorption. Endokrynol Pol. 2012;63:318\u201323.","journal-title":"Endokrynol Pol."},{"key":"116_CR49","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","volume":"18","author":"JR Garber","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18:988\u20131028.","journal-title":"Endocr Pract."},{"key":"116_CR50","first-page":"245","volume":"10","author":"JS Bevan","year":"1986","unstructured":"Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes (Lond). 1986;10:245\u20136.","journal-title":"Int J Obes (Lond)."},{"key":"116_CR51","volume-title":"Management of diabetes: a national clinical guideline\u00a0116","author":"Scottish Intercollegiate Guideline Network","year":"2010","unstructured":"Network Scottish Intercollegiate Guideline. Management of diabetes: a national clinical guideline\u00a0116. Edinburgh: Healthcare Improvement Scotland; 2010."},{"key":"116_CR52","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMra071600","volume":"357","author":"PHR Green","year":"2007","unstructured":"Green PHR, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731\u201343.","journal-title":"N Engl J Med"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-015-0116-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-015-0116-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-015-0116-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T15:44:49Z","timestamp":1567439089000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-015-0116-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1007\/s40268-015-0116-6","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}